International Biotechnology Trust PLC Clovis Oncology, Inc. Transaction History

International Biotechnology Trust PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	BUY	$29.37 - $49.48 $922,218 - $1.55 Million	31,400 New	31,400 $1.46 Million
Q2 2018 Aug 13, 2018	SELL	$42.06 - $62.4 $3.2 Million - $4.74 Million	-76,000 Closed	0 $0
Q4 2017 Mar 02, 2018	BUY	$57.69 - $84.58 $1.15 Million - $1.69 Million	20,000 Added 35.71%	76,000 $5.17 Million
Q3 2017 Mar 02, 2018	BUY	$67.17 - $84.81 $1.41 Million - $1.78 Million	21,000 Added 60.0%	56,000 $4.61 Million
Q2 2017 Mar 02, 2018	BUY	N/A	15,000 Added 75.0%	35,000 $3.28 Million
Q1 2017 Mar 02, 2018	SELL	N/A	-55,000 Reduced 73.33%	20,000 $1.27 Million
Q4 2016 Mar 02, 2018	BUY	N/A	75,000	75,000 $3.33 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

Stay updated on International Biotechnology Trust PLC with notifications on news.